Discover
BBNX
Beta Bionics, Inc.
16.70
2 x 11.90
2 x 20.48
bid
ask
+
1.03
6.57%
2 @ 05:53 AM
16.01 -0.69 (4.13%)
| Ytd | -45.19% | |
| 1y | 19.80% |
15.88
day range
16.84
8.80
52 week range
32.71
| Open | 15.91 | Prev Close | 15.67 | Low | 15.88 | High | 16.84 | Mkt Cap | 744.18M |
| Vol | 785.25K | Avg Vol | 986.24K | EPS | -1.37 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 4.22 | Inst. Own | 104.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 12.25 | 200-d Avg | 18.16 | 1yr Est | 23.67 |
| Income Statement | |||
| Total Revenue | 27.63M | ||
| Revenues (USD) | 27.63M | ||
| Cost of Revenue | 11.19M | ||
| Gross Profit | 16.44M | ||
| Operating Expenses | 40.71M | ||
| Research and Development Expense | 10.36M | ||
| Selling, General and Administrative Expense | 30.35M | ||
| Operating Income | -24.27M | ||
| Net Income | -21.89M | ||
| Net Income Common Stock | -21.89M | ||
| Net Income Common Stock (USD) | -21.89M | ||
| Consolidated Income | -21.89M | ||
| Earnings per Basic Share | -0.49 | ||
| Earnings per Basic Share (USD) | -0.49 | ||
| Earnings per Diluted Share | -0.49 | ||
| Earning Before Interest & Taxes (EBIT) | -21.89M | ||
| Earning Before Interest & Taxes (USD) | -21.89M | ||
| Weighted Average Shares | 44.44M | ||
| Weighted Average Shares Diluted | 44.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.31M | ||
| Cash and Equivalents (USD) | 30.31M | ||
| Investments | 209.18M | ||
| Investments Current | 169.31M | ||
| Investments Non-Current | 39.87M | ||
| Trade and Non-Trade Receivables | 15.75M | ||
| Current Assets | 247.99M | ||
| Property, Plant & Equipment Net | 16.39M | ||
| Total Assets | 304.42M | ||
| Debt Current | 1.84M | ||
| Total Debt | 6.91M | ||
| Current Liabilities | 23.19M | ||
| Debt Non-Current | 5.07M | ||
| Total Liabilities | 33.17M | ||
| Accumulated Retained Earnings (Deficit) | -391.83M | ||
| Accumulated Other Comprehensive Income | -96.00K | ||
| Shareholders Equity | 271.25M | ||
| Shareholders Equity (USD) | 271.25M | ||
| Assets Non-Current | 56.43M | ||
| Total Debt (USD) | 6.91M | ||
| Deferred Revenue | 5.06M | ||
| Inventory | 23.73M | ||
| Liabilities Non-Current | 9.98M | ||
| Trade and Non-Trade Payables | 2.32M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 987.00K | ||
| Net Cash Flow from Financing | 623.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.37M | ||
| Capital Expenditure | -1.38M | ||
| Issuance (Purchase) of Equity Shares | 623.00K | ||
| Net Cash Flow from Investing | 21.84M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 23.22M | ||
| Net Cash Flow from Operations | -23.83M | ||
| Share Based Compensation | 5.41M | ||